Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression

Veterinary Microbiology

Volumn 138, Issue 3-4, 2009, Pages 318-324

  Kim, Taejung ^a   Toan, Nguyen Tat ^a   Seo, Jayoung ^a   Jung, Bockgie ^a   Lee, Jaeil ^a   Lee, Bongjoo ^a  

^a Chonnam National University   (South Korea)

Author keywords

Bordetella bronchiseptica; Heterologous antigen expression vehicle; Porcine circovirus type 2

Indexed keywords

CAPSID PROTEIN; LIVE VACCINE; PROTEIN ANTIBODY; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIUM MUTANT; BORDETELLA BRONCHISEPTICA; CIRCOVIRIDAE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMOLOGOUS RECOMBINATION; IMMUNIZATION; LYMPH NODE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PORCINE CIRCOVIRUS TYPE 2; PROTEIN EXPRESSION; SWINE; VIRUS INFECTION;

ADMINISTRATION, INTRANASAL; ANIMALS; BORDETELLA BRONCHISEPTICA; CAPSID PROTEINS; CIRCOVIRUS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, BACTERIAL; MICE; MUTATION; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; SWINE; VIRAL PROTEINS; VIRAL VACCINES;

BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; MIRIDAE; MUS; PORCINE CIRCOVIRUS 2; SUIDAE;

EID: 69349086027     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.04.014     Document Type: Article

References (31)

1. Allan G.M., McNeilly F., Ellis J., Krakowka S., Meehan B., McNair I., Walker I., and Kennedy S. Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication. Arch. Virol. 145 (2000) 2421-2429
2. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. Short Protocols in Molecular Biology (2002), John Wiley & Sons, New York
3. Blanchard P., Mahé D., Cariolet R., Truong C., Le Dimna M., Arnauld C., Rose N., Eveno E., Albina E., Madec F., and Jestin A. An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome. Vet. Microbiol. 94 (2003) 183-194
4. Cho H.S., Kim T.J., Lee J.I., and Park N.Y. Serodiagnostic comparison of enzyme-linked immunosorbent assay and surface plasmon resonance for the detection of antibody to porcine circovirus type 2. Can. J. Vet. Res. 70 (2006) 263-268
5. Chung W.B., Chan W.H., Chaung H.C., Lien Y., Wu C.C., and Huang Y.L. Real-time PCR for quantitation of porcine reproductive and respiratory syndrome virus and porcine circovirus type 2 in naturally-infected and challenged pigs. J. Virol. Methods 124 (2005) 11-19
6. Datsenko K.A., and Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6640-6645
7. Fan H., Ju C., Tong T., Huang H., Lv J., and Chen H. Immunogenicity of empty capsids of porcine circovirus type 2 produced in insect cells. Vet. Res. Commun. 31 (2007) 487-496
8. Fan H., Pan Y., Fang L., Wang D., Wang S., Jiang Y., Chen H., and Xiao S. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J. Virol. Methods 150 (2008) 21-26
9. Fenaux M., Opriessnig T., Halbur P.G., Elvinger F., and Meng X.J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J. Virol. 78 (2004) 6297-6303
10. Frey A., Di Canzio J., and Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J. Immunol. Methods 221 (1998) 35-41
11. Ho S.Y., Chua S.Q., Foo D.G.W., Locht C., Chow V.T., Poh C.L., and Alonso S. Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates. Infect. Immun. 76 (2008) 111-119
12. Ju C., Fan H., Tan Y., Liu Z., Xi X., Cao S., Wu B., and Chen H. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Vet. Microbiol. 109 (2005) 179-190
13. Kamstrup S., Barfoed A.M., Frimann T.H., Ladekjær-Mikkelsen A.S., and Bøtner A. Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 22 (2004) 1358-1361
14. Kennedy S., Moffett D., McNeilly F., Meehan B., Ellis J., Krakowka S., and Allan G.M. Reproduction of lesions of postweaning multisystemic wasting syndrome by infection of conventional pigs with porcine circovirus type 2 alone or in combination with porcine parvovirus. J. Comp. Pathol. 122 (2000) 9-24
15. Krakowka S., Ellis J.A., McNeilly F., Ringler S., Rings D.M., and Allan G. Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus 2 (PCV2). Vet. Pathol. 38 (2001) 31-42
16. Liu Q., Wang L., Willson P., and Babiuk L.A. Quantitative, competitive PCR analysis of porcine circovirus DNA in serum from pigs with postweaning multisystemic wasting syndrome. J. Clin. Microbiol. 38 (2000) 3474-3477
17. Liu Q., Wang L., Willson P., O'Connor B., Keenliside J., Chirino-Trejo M., Meléndez R., and Babiuk L. Seroprevalence of porcine circovirus type 2 in swine populations in Canada and Costa Rica. Can. J. Vet. Res. 66 (2002) 225-231
18. Mahé D., Blanchard P., Truong C., Arnauld C., Le Cann P., Cariolet R., Madec F., Albina E., and Jestin A. Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J. Gen. Virol. 81 (2000) 1815-1824
19. McArthur J.D., West N.P., Cole J.N., Jungnitz H., Guzmán C.A., Chin J., Lehrbach P.R., Djordjevic S.P., and Walker M.J. An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. FEMS Microbiol. Lett. 221 (2003) 7-16
20. Mielcarek N., Alonso S., and Locht C. Nasal vaccination using live bacterial vectors. Adv. Drug Deliv. Rev. 51 (2001) 55-69
21. Mielcarek N., Debrie A.S., Raze D., Quatannens J., Engle J., Goldman W.E., and Locht C. Attenuated Bordetella pertussis: new live vaccines for intranasal immunization. Vaccine 24 (2006) S2/54-55
22. Nawagitgul P., Morozov I., Bolin S.R., Harms P.A., Sorden S.D., and Paul P.S. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J. Gen. Virol. 81 (2000) 2281-2287
23. Opriessnig T., Yu S., Gallup J.M., Evans R.B., Fenaux M., Pallares F., Thacker E.L., Brockus C.W., Ackermann M.R., Thomas P., Meng X.J., and Halbur P.G. Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet. Pathol. 40 (2003) 521-529
24. Resendes A., Segalés J., Balasch M., Calsamiglia M., Sibila M., Ellerbrok H., Mateu E., Plana-Durán J., Mankertz A., and Domingo M. Lack of an effect of a commercial vaccine adjuvant on the development of postweaning multisystemic wasting syndrome (PMWS) in porcine circovirus type 2 (PCV2) experimentally infected conventional pigs. Vet. Res. 35 (2004) 83-90
25. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual (2001), Cold Spring Harbor Laboratory Press, New York
26. Segalés J., Domingo M., Chianini F., Majó N., Domínguez J., Darwich L., and Mateu E. Immunosuppression in postweaning multisystemic wasting syndrome affected pigs. Vet. Microbiol. 98 (2004) 151-158
27. Stevenson A., and Roberts M. Intranasal immunisation against tetanus with an attenuated Bordetella bronchiseptica vector expressing FrgC: improved immunogenicity using a Bvg-regulated promoter to express FrgC. Vaccine 22 (2004) 4300-4305
28. Wang K., Huang L., Kong J., and Zhang X. Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination. J. Virol. Methods 150 (2008) 1-6
29. Wang X., Jiang P., Li Y., Jiang W., and Dong X. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2. Vet. Microbiol. 121 (2007) 215-224
30. Wang X., Jiang W., Jiang P., Li Y., Feng Z., and Xu J. Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice. Vaccine 24 (2006) 3374-3380
31. Yu S., Opriessnig T., Kitikoon P., Nilunol D., Halbur P.G., and Thacker E. Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune cells in early infected pigs. Vet. Immunol. Immunopathol. 115 (2007) 261-272